India's Serum Institute, the world's largest vaccine manufacturer, despatched on Tuesday its first batch of vaccine shots for the Covax global inoculation programme.
The global vaccine procurement and equitable distribution effort aims to secure vaccines for at least the most vulnerable 20 percent in every country.
Covax, led by the World Health Organization and the GAVI alliance, has struck agreements with manufacturers for two billion doses in 2021 and has the option for another billion.
This includes 1.1 billion doses from the Serum Institute, which is producing the AstraZeneca and Novavax vaccines.
WHO Southeast Asia tweeted photos of the first shipments being loaded onto a truck at Serum's manufacturing facility in Pune in western India.
Serum has already supplied the Indian government with millions of doses of the AstraZeneca vaccine as well as other poorer nations.
The company's head Adar Poonawalla on Sunday urged other countries to be "patient", saying it had been instructed to prioritise its home market over exports.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Serum Institute Says Working To Develop Monkeypox Vaccine Serum Institute's New "High Efficacy" Malaria Vaccine Rolls Out In Africa Serum Institute Begins Shipments Of Malaria Vaccine 'R21/Matrix-M' To Africa Trump Says US Ownership Of Greenland Absolutely Necessary, Nation Responds Delta Airline Passenger Gets Frustrated After His First-Class Seat Was Given To Service Dog Congress Leader Files Complaint Against Allu Arjun Over Scene In 'Pushpa 2' 2 Men Dragged For 300 Metres By Truck In UP's Agra, Driver Arrested: Cops German President Urges Unity After "Dark Shadow" Of Christmas Market Attack Former US President Bill Clinton Hospitalised With Fever Track Latest News Live on NDTV.com and get news updates from India and around the world.